| 词条 | Fanconi syndrome |
| 释义 |
| name = Fanconi syndrome | synonyms = | image = | caption = | pronounce = | field = | symptoms = | complications = | onset = | duration = | types = | causes = | risks = | diagnosis = | differential = | prevention = | treatment = | medication = | prognosis = | frequency = | deaths = }} Fanconi syndrome or Fanconi's syndrome ({{IPAc-en|lang|f|ɑː|n|ˈ|k|oʊ|n|i}}, {{IPAc-en|f|æ|n|-}}) is a syndrome of inadequate reabsorption in the proximal renal tubules[1] of the kidney. The syndrome can be caused by various underlying congenital or acquired diseases, by toxicity (for example, from toxic heavy metals), or by adverse drug reactions.[2] It results in various small molecules of metabolism being passed into the urine instead of being reabsorbed from the tubular fluid (for example, glucose, amino acids, uric acid, phosphate, and bicarbonate). Fanconi syndrome affects the proximal tubules, namely, the proximal convoluted tubule (PCT), which is the first part of the tubule to process fluid after it is filtered through the glomerulus, and the proximal straight tubule (pars recta), which leads to the descending limb of loop of Henle. Different forms of Fanconi syndrome can affect different functions of the proximal tubule, and result in different complications. The loss of bicarbonate results in type 2 or proximal renal tubular acidosis. The loss of phosphate results in the bone diseases rickets and osteomalacia (even with adequate vitamin D and calcium levels), because phosphate is necessary for bone development in children and even for ongoing bone metabolism in adults.[3] Presentation{{Main|renal tubular acidosis}}The clinical features of proximal renal tubular acidosis are:
Other features of the generalized proximal tubular dysfunction of the Fanconi syndrome are:
CausesIn contrast to Hartnup disease and related tubular conditions, Fanconi syndrome affects the transport of many different substances, so is not considered to be a defect in a specific channel, but a more general defect in the function of the proximal tubules.[4] Different diseases underlie Fanconi syndrome; they can be inherited, congenital, or acquired. InheritedCystinosis is the most common cause of Fanconi syndrome in children. Other recognised causes are Wilson's disease (a genetically inherited condition of copper metabolism), Lowe syndrome, tyrosinemia (type I),[5] galactosemia, glycogen storage diseases, and hereditary fructose intolerance. Two forms, Dent's disease and Lowe syndrome, are X linked.[6] A recently described form of this disease is due to a mutation in the peroxisomal protein EHHADH.[7] This mutation misdirects the EHHADH to the mitochondria. This interfers with respiratory complex I and with beta oxidation of fatty acids. The end result is a decrease in the ability of the mitochondria to produce ATP. It was shown that a specific mutation (R76W) of HNF4A, a gene encoding a transcription factor, causes Fanconi syndrome in human.[8] In the kidney, HNF4A is expressed in the proximal tubules specifically.[9] Deletion of Hnf4a in the developing mouse kidney caused Fanconi syndrome phenotypes including polyruia, polydipsia, glycosuria, and phosphaturia.[10] The Hnf4a mutant kidney showed a defect in the formation of proximal tubules.[10] AcquiredIt is possible to acquire this disease later in life. Causes include ingesting expired tetracyclines (where tetracycline changes to form epitetracycline and anhydrotetracycline which damage proximal tubule), and as a side effect of tenofovir in cases of pre-existing renal impairment.[11][12] In the HIV population, Fanconi syndrome can develop secondary to the use of an antiretroviral regimen containing tenofovir and didanosine.[13] Lead poisoning also leads to Fanconi syndrome.[14]Multiple myeloma or monoclonal gammopathy of undetermined significance can also cause the condition.[15]Additionally, Fanconi Syndrome can develop as a secondary or tertiary effect of certain autoimmune disorders.[16][17] DiagnosisUrine routine, might not be completely reliable but is an important indicator TreatmentTreatment of children with Fanconi syndrome mainly consists of replacement of substances lost in the urine (mainly fluid and bicarbonate). EponymIt is named after Guido Fanconi, a Swiss pediatrician, although various other scientists, including George Lignac, contributed to its study. It should not be confused with Fanconi anemia, a separate disease. See also
References1. ^{{DorlandsDict|nine/000952604|Fanconi syndrome}} 2. ^Fanconi Syndrome at Merck Manual Home Health Handbook 3. ^{{cite journal | vauthors = Magen D, Berger L, Coady MJ, Ilivitzki A, Militianu D, Tieder M, Selig S, Lapointe JY, Zelikovic I, Skorecki K | title = A loss-of-function mutation in NaPi-IIa and renal Fanconi's syndrome | journal = The New England Journal of Medicine | volume = 362 | issue = 12 | pages = 1102–9 | date = March 2010 | pmid = 20335586 | doi = 10.1056/NEJMoa0905647 }} 4. ^{{EMedicine|article|981774|Fanconi Syndrome}} 5. ^{{cite journal | vauthors = Cochat P, Pichault V, Bacchetta J, Dubourg L, Sabot JF, Saban C, Daudon M, Liutkus A | title = Nephrolithiasis related to inborn metabolic diseases | journal = Pediatric Nephrology | volume = 25 | issue = 3 | pages = 415–24 | date = March 2010 | pmid = 19156444 | pmc = 2810370 | doi = 10.1007/s00467-008-1085-6 }} 6. ^{{cite journal | vauthors = Vilasi A, Cutillas PR, Maher AD, Zirah SF, Capasso G, Norden AW, Holmes E, Nicholson JK, Unwin RJ | title = Combined proteomic and metabonomic studies in three genetic forms of the renal Fanconi syndrome | journal = American Journal of Physiology. Renal Physiology | volume = 293 | issue = 2 | pages = F456-67 | date = August 2007 | pmid = 17494094 | doi = 10.1152/ajprenal.00095.2007 }} 7. ^{{cite journal | vauthors = Assmann N, Dettmer K, Simbuerger JM, Broeker C, Nuernberger N, Renner K, Courtneidge H, Klootwijk ED, Duerkop A, Hall A, Kleta R, Oefner PJ, Reichold M, Reinders J | title = Renal Fanconi Syndrome Is Caused by a Mistargeting-Based Mitochondriopathy | journal = Cell Reports | volume = 15 | issue = 7 | pages = 1423–1429 | date = May 2016 | pmid = 27160910 | doi = 10.1016/j.celrep.2016.04.037 }} 8. ^{{cite journal | vauthors = Hamilton AJ, Bingham C, McDonald TJ, Cook PR, Caswell RC, Weedon MN, Oram RA, Shields BM, Shepherd M, Inward CD, Hamilton-Shield JP, Kohlhase J, Ellard S, Hattersley AT | title = The HNF4A R76W mutation causes atypical dominant Fanconi syndrome in addition to a β cell phenotype | journal = Journal of Medical Genetics | volume = 51 | issue = 3 | pages = 165–9 | date = March 2014 | pmid = 24285859 | pmc = 3932761 | doi = 10.1136/jmedgenet-2013-102066 | url = https://jmg.bmj.com/content/51/3/165 }} 9. ^{{cite journal | vauthors = Lee JW, Chou CL, Knepper MA | title = Deep Sequencing in Microdissected Renal Tubules Identifies Nephron Segment-Specific Transcriptomes | journal = Journal of the American Society of Nephrology | volume = 26 | issue = 11 | pages = 2669–77 | date = November 2015 | pmid = 25817355 | pmc = 4625681 | doi = 10.1681/ASN.2014111067 | url = https://jasn.asnjournals.org/content/26/11/2669 }} 10. ^1 {{cite journal | vauthors = Marable SS, Chung E, Adam M, Potter SS, Park JS | title = Hnf4a deletion in the mouse kidney phenocopies Fanconi renotubular syndrome | journal = JCI Insight | volume = 3 | issue = 14 | date = July 2018 | pmid = 30046000 | pmc = 6124415 | doi = 10.1172/jci.insight.97497 | url = https://insight.jci.org/articles/view/97497 }} 11. ^Viread Label Information, U.S. Food and Drug Administration (FDA)), 2008-04-11 12. ^[https://web.archive.org/web/20090518085840/http://www.hivandhepatitis.com/recent/2008/101408_c.html Tenofovir (Viread) Associated with Mild Kidney Function Impairment, but not Clinically Relevant Renal Disease], hivandhepatitis.com, 2008-10-14 13. ^{{cite journal | vauthors = Irizarry-Alvarado JM, Dwyer JP, Brumble LM, Alvarez S, Mendez JC | title = Proximal tubular dysfunction associated with tenofovir and didanosine causing Fanconi syndrome and diabetes insipidus: a report of 3 cases | journal = The AIDS Reader | volume = 19 | issue = 3 | pages = 114–21 | date = March 2009 | pmid = 19334328 }} 14. ^{{cite journal | vauthors = Barbier O, Jacquillet G, Tauc M, Cougnon M, Poujeol P | title = Effect of heavy metals on, and handling by, the kidney | journal = Nephron Physiology | volume = 99 | issue = 4 | pages = 105–10 | year = 2005 | pmid = 15722646 | doi = 10.1159/000083981 }} 15. ^{{cite journal | vauthors = Hashimoto T, Arakawa K, Ohta Y, Suehiro T, Uesugi N, Nakayama M, Tsuchihashi T | title = Acquired fanconi syndrome with osteomalacia secondary to monoclonal gammopathy of undetermined significance | journal = Internal Medicine | volume = 46 | issue = 5 | pages = 241–5 | year = 2007 | pmid = 17329920 | doi = 10.2169/internalmedicine.46.1882 }} 16. ^{{cite web|title=Fanconi Syndrome|website=The Medical Dictionary|url=http://the-medical-dictionary.com/fanconi_syndrome_article_5.htm}} 17. ^{{cite journal | vauthors = Kobayashi T, Muto S, Nemoto J, Miyata Y, Ishiharajima S, Hironaka M, Asano Y, Kusano E | title = Fanconi's syndrome and distal (type 1) renal tubular acidosis in a patient with primary Sjögren's syndrome with monoclonal gammopathy of undetermined significance | journal = Clinical Nephrology | volume = 65 | issue = 6 | pages = 427–32 | date = June 2006 | pmid = 16792139 | doi = 10.5414/CNP65427 }} External links{{Medical resources| DiseasesDB = 11687 | ICD10 = {{ICD10|E|72|0|e|70}} | ICD9 = {{ICD9|270.0}} | ICDO = | OMIM = | MedlinePlus = 000333 | eMedicineSubj = ped | eMedicineTopic = 756 | MeshID = D005198 }}{{Amino acid metabolic pathology}}{{Nephrology}} 3 : Amino acid metabolism disorders|Kidney diseases|Syndromes |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。